METHODS AND COMPOSITIONS FOR USE OF A COCCIDIOSIS VACCINE
The present invention relates to a coccidiosis vaccine to protect poultry against Eimeria infection, comprising a recombinant avian adenovirus vector comprising in frame a (heterologous) promoter linked to a hydrophobic signal sequence for membrane anchoring, or linked to an hydrophobic secretion si...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SHEPPARD, MICHAEL G |
| description | The present invention relates to a coccidiosis vaccine to protect poultry against Eimeria infection, comprising a recombinant avian adenovirus vector comprising in frame a (heterologous) promoter linked to a hydrophobic signal sequence for membrane anchoring, or linked to an hydrophobic secretion signal and a cleavage site to allow secretion; a multiple cloning site for in frame insertion of an Eimeria antigen ORF such as derived from the r56, 82 kDa, and/or TFP250 antigens; a polyadenylation signal; and an avian adenovirus genome.
La présente invention concerne un vaccin contre la coccidiose pour protéger les volailles contre une infection par Eimeria, comprenant un vecteur d'adénovirus aviaire recombinant comprenant en phase un promoteur (hétérologue) lié à une séquence signal hydrophobe pour l'ancrage membranaire, ou lié à un signal de sécrétion hydrophobe et un site de clivage pour permettre la sécrétion; un site de clonage multiple pour l'insertion dans le cadre d'un ORF d'antigène d'Eimeria tel que celui dérivé des antigènes r56, 82 kDa, et/ou TFP250; un signal de polyadénylation; et un génome d'adénovirus aviaire. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2010068968A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2010068968A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2010068968A13</originalsourceid><addsrcrecordid>eNrjZLD0dQ3x8HcJVnD0c1Fw9vcN8A_2DPH09wtWcPMPUggNdlXwd1NwBMo4O3u6eAIlgxXCHIFsP1ceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIf7m9kYGhgYGZhaWbhaGhMnCoAFq0pfQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS AND COMPOSITIONS FOR USE OF A COCCIDIOSIS VACCINE</title><source>esp@cenet</source><creator>SHEPPARD, MICHAEL G</creator><creatorcontrib>SHEPPARD, MICHAEL G</creatorcontrib><description>The present invention relates to a coccidiosis vaccine to protect poultry against Eimeria infection, comprising a recombinant avian adenovirus vector comprising in frame a (heterologous) promoter linked to a hydrophobic signal sequence for membrane anchoring, or linked to an hydrophobic secretion signal and a cleavage site to allow secretion; a multiple cloning site for in frame insertion of an Eimeria antigen ORF such as derived from the r56, 82 kDa, and/or TFP250 antigens; a polyadenylation signal; and an avian adenovirus genome.
La présente invention concerne un vaccin contre la coccidiose pour protéger les volailles contre une infection par Eimeria, comprenant un vecteur d'adénovirus aviaire recombinant comprenant en phase un promoteur (hétérologue) lié à une séquence signal hydrophobe pour l'ancrage membranaire, ou lié à un signal de sécrétion hydrophobe et un site de clivage pour permettre la sécrétion; un site de clonage multiple pour l'insertion dans le cadre d'un ORF d'antigène d'Eimeria tel que celui dérivé des antigènes r56, 82 kDa, et/ou TFP250; un signal de polyadénylation; et un génome d'adénovirus aviaire.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100624&DB=EPODOC&CC=WO&NR=2010068968A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100624&DB=EPODOC&CC=WO&NR=2010068968A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHEPPARD, MICHAEL G</creatorcontrib><title>METHODS AND COMPOSITIONS FOR USE OF A COCCIDIOSIS VACCINE</title><description>The present invention relates to a coccidiosis vaccine to protect poultry against Eimeria infection, comprising a recombinant avian adenovirus vector comprising in frame a (heterologous) promoter linked to a hydrophobic signal sequence for membrane anchoring, or linked to an hydrophobic secretion signal and a cleavage site to allow secretion; a multiple cloning site for in frame insertion of an Eimeria antigen ORF such as derived from the r56, 82 kDa, and/or TFP250 antigens; a polyadenylation signal; and an avian adenovirus genome.
La présente invention concerne un vaccin contre la coccidiose pour protéger les volailles contre une infection par Eimeria, comprenant un vecteur d'adénovirus aviaire recombinant comprenant en phase un promoteur (hétérologue) lié à une séquence signal hydrophobe pour l'ancrage membranaire, ou lié à un signal de sécrétion hydrophobe et un site de clivage pour permettre la sécrétion; un site de clonage multiple pour l'insertion dans le cadre d'un ORF d'antigène d'Eimeria tel que celui dérivé des antigènes r56, 82 kDa, et/ou TFP250; un signal de polyadénylation; et un génome d'adénovirus aviaire.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD0dQ3x8HcJVnD0c1Fw9vcN8A_2DPH09wtWcPMPUggNdlXwd1NwBMo4O3u6eAIlgxXCHIFsP1ceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIf7m9kYGhgYGZhaWbhaGhMnCoAFq0pfQ</recordid><startdate>20100624</startdate><enddate>20100624</enddate><creator>SHEPPARD, MICHAEL G</creator><scope>EVB</scope></search><sort><creationdate>20100624</creationdate><title>METHODS AND COMPOSITIONS FOR USE OF A COCCIDIOSIS VACCINE</title><author>SHEPPARD, MICHAEL G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2010068968A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2010</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SHEPPARD, MICHAEL G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHEPPARD, MICHAEL G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS AND COMPOSITIONS FOR USE OF A COCCIDIOSIS VACCINE</title><date>2010-06-24</date><risdate>2010</risdate><abstract>The present invention relates to a coccidiosis vaccine to protect poultry against Eimeria infection, comprising a recombinant avian adenovirus vector comprising in frame a (heterologous) promoter linked to a hydrophobic signal sequence for membrane anchoring, or linked to an hydrophobic secretion signal and a cleavage site to allow secretion; a multiple cloning site for in frame insertion of an Eimeria antigen ORF such as derived from the r56, 82 kDa, and/or TFP250 antigens; a polyadenylation signal; and an avian adenovirus genome.
La présente invention concerne un vaccin contre la coccidiose pour protéger les volailles contre une infection par Eimeria, comprenant un vecteur d'adénovirus aviaire recombinant comprenant en phase un promoteur (hétérologue) lié à une séquence signal hydrophobe pour l'ancrage membranaire, ou lié à un signal de sécrétion hydrophobe et un site de clivage pour permettre la sécrétion; un site de clonage multiple pour l'insertion dans le cadre d'un ORF d'antigène d'Eimeria tel que celui dérivé des antigènes r56, 82 kDa, et/ou TFP250; un signal de polyadénylation; et un génome d'adénovirus aviaire.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2010068968A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | METHODS AND COMPOSITIONS FOR USE OF A COCCIDIOSIS VACCINE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T04%3A29%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHEPPARD,%20MICHAEL%20G&rft.date=2010-06-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2010068968A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |